PARADROMICS

In News

FDA approves Paradromics’ brain-computer interface trial for speech restoration - statnews.com

statnews.com - Nov 20, 2025

Neuralink competitor Paradromics completes first human implant - CNBC

CNBC - Jun 02, 2025

Paradromics Gets FDA Approval to Trial Its Brain Implant in People - WIRED

WIRED - Nov 20, 2025

Paradromics gets FDA green light for BCI study - MassDevice

MassDevice - Nov 20, 2025

Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus® Brain-Computer Interface - Business Wire

Business Wire - Nov 20, 2025

Neuralink Rival Paradromics Cleared to Start Brain Implant Trial - Bloomberg.com

Bloomberg.com - Nov 20, 2025

Speech-restoring brain chip gets FDA approval for human trial - New Atlas

New Atlas - Nov 21, 2025

Paradromics Gets FDA Green Light for Brain Implant Trials - The Tech Buzz

The Tech Buzz - Nov 20, 2025

Austin startup prepares for clinical trial after first human brain-computer interface test - Spectrum News

Spectrum News - Sep 03, 2025

Austin's Paradromics advances Brain-Computer Interface with successful surgery - KEYE

KEYE - Jun 27, 2025

Austin brain implant firm gets FDA approval for first long-term clinical trial - Austin American-Statesman

Austin American-Statesman - Nov 25, 2025

Paradromics challenges Neuralink: First human brain implant sets stage for high-resolution BCI Race - Tech Funding News

Tech Funding News - Jun 06, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment